Proteomics: a major new technology for the drug discovery process.

Proteomics: a major new technology for the drug discovery process.

Proteomics is a new enabling technology that is being integrated into the drug discovery process. This will facilitate the systematic analysis of proteins across any biological system or disease, forwarding new targets and information on mode of action, toxicology and surrogate markers. Proteomics i...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Page, M, Amess, B, Rohlff, C, Stubberfield, C, Parekh, R
Formatua:	Journal article
Hizkuntza:	English
Argitaratua:	1999

Antzeko izenburuak

Applying genomic and proteomic microarray technology in drug discovery /
nork: 224468 Matson, Robert S.
Argitaratua: (c201)

Applying genomic and proteomic microarray technology in drug discovery /
nork: 224468 Matson, Robert S.
Argitaratua: (2004)

Tissue proteomics : pathways, biomarkers, and drug discovery /
nork: Liu, Brian C.-S., et al.
Argitaratua: (2008)

Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties.
nork: Page, M, et al.
Argitaratua: (1999)

Comparative genomics and proteomics in drug discovery /
nork: Parrington, John, et al.
Argitaratua: (2006)

Bioinformatics methods and applications : genomics, proteomics and drug discovery /
nork: 384476 Rastogi, S. C., et al.
Argitaratua: (c200)

Proteomic comparison of human and great ape blood plasma reveals conserved glycosylation and differences in thyroid hormone metabolism.
nork: Gagneux, P, et al.
Argitaratua: (2001)

Discovery of Screening Biomarkers for Major Depressive Disorder in Remission by Proteomic Approach
nork: Hyebin Choi, et al.
Argitaratua: (2021-03-01)

Chemical Proteomics Applied to Target Identification and Drug Discovery
nork: Steven H.L. Verhelst, et al.
Argitaratua: (2005-02-01)

Aptamer-based multiplexed proteomic technology for biomarker discovery.
nork: Larry Gold, et al.
Argitaratua: (2010-12-01)

The Drug Discovery and Development Process in the New Millennium
nork: Michael D Levy
Argitaratua: (2000-01-01)

Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD
nork: Thomas J. Hedl, et al.
Argitaratua: (2019-06-01)

Process optimization in drug discovery
nork: Roberts, Rebecca Anne, M.B.A. Massachusetts Institute of Technology
Argitaratua: (2007)

Proteomics for biological discovery /
nork: 183962 Veenstra, Timothy D., et al.
Argitaratua: (2006)

Therapeutic Target Identification and Drug Discovery Driven by Chemical Proteomics
nork: Mingjie Zou, et al.
Argitaratua: (2024-07-01)

Editorial: Mass spectrometry-based proteomics in drug discovery and development
nork: Martin Pejchinovski, et al.
Argitaratua: (2024-07-01)

Systematic in silico Evaluation of Leishmania spp. Proteomes for Drug Discovery
nork: Crhisllane Rafaele dos Santos Vasconcelos, et al.
Argitaratua: (2021-04-01)

Drug Discovery Process
nork: Kenichi KUWASHIMA
Argitaratua: (2016-05-01)

Technologies for Proteome-Wide Discovery of Extracellular Host-Pathogen Interactions
nork: Nadia Martinez-Martin
Argitaratua: (2017-01-01)

Knowledge discovery in proteomics /
nork: 193240 Jurisica, Igor, et al.
Argitaratua: (2006)

Discovery of new liver fibrosis markers in hepatitis C patients using proteomics
nork: Gangadharan, B, et al.
Argitaratua: (2011)

Patient-derived tumoroids and proteomic signatures: tools for early drug discovery
nork: Hélène Lê, et al.
Argitaratua: (2024-04-01)

Production of Proteins of the SARS-CoV‑2 Proteome for Drug Discovery
nork: Choon Kim, et al.
Argitaratua: (2021-07-01)

Cysteine-specific Chemical Proteomics: From Target Identification to Drug Discovery
nork: Dominic G. Hoch, et al.
Argitaratua: (2016-11-01)

Deep proteome profiling promotes whole proteome characterization and drug discovery for esophageal squamous cell carcinoma
nork: Wei Liu, et al.
Argitaratua: (2022-03-01)

Proteome discovery pipeline for mass spectrometry-based proteomics
nork: Buck Charles R, et al.
Argitaratua: (2008-07-01)

The Major Role of Clinicians in the Discovery of Off-Label Drug Therapies
nork: DeMonaco, Harold J., et al.
Argitaratua: (2005)

Acanthocheilonema viteae: phosphorylcholine is attached to the major excretory-secretory product via an N-linked glycan.
nork: Harnett, W, et al.
Argitaratua: (1993)

Drug discovery and development: technology in transition
nork: Hill, RG, et al.
Argitaratua: (2021)

Drug discovery and development : technology in transition /
nork: Rang, H. P.
Argitaratua: (2006)

SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
nork: Xiaonan Liu, et al.
Argitaratua: (2021-10-01)

Proteomic Approaches in Biomarker Discovery: New Perspectives in Cancer Diagnostics
nork: Petra Hudler, et al.
Argitaratua: (2014-01-01)

Quality not Quantity: The Role of Marine Natural Products in Drug Discovery and Reverse Chemical Proteomics
nork: Andrew M. Piggott, et al.
Argitaratua: (2005-06-01)

Proteomics for cancer biomarker discovery
nork: Volchenboum, Samuel Louis
Argitaratua: (2008)

Proteomics Discovery of Disease Biomarkers
nork: Mamoun Ahram, et al.
Argitaratua: (2008-01-01)

Proteomics Discovery of Disease Biomarkers
nork: Mamoun Ahram, et al.
Argitaratua: (2008-01-01)

New drug discovery and development /
nork: Lednicer, Daniel, 1929-
Argitaratua: (2007)

New drug discovery: Where are we heading to?
nork: M R Yadav
Argitaratua: (2013-01-01)

Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis.
nork: Fischer, R, et al.
Argitaratua: (2012)

Epigenetic protein families: a new frontier for drug discovery.
nork: Arrowsmith, C, et al.
Argitaratua: (2012)